Komori
Other Disclosures4041Nippon Soda Co.,Ltd.Materials and Chemicals

Expansion of manufacturing facilities for the pharmaceutical excipient “NISSO HPC” completed; commercial operations commenced

The expansion of the manufacturing facilities for the pharmaceutical excipient “NISSO HPC” was completed, and commercial operations commenced in July 2026. Production capacity increased to 1.5 times the previous level. The company also opened a European technical center, began direct sales in India, and obtained environmental certification.

Worth reading
73In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
1.5
Production capacity relative to the previous level (times)
Wording
Definitive
How definitive the wording is.

Announced details

NISSO HPCCELNYCellulose Technical Application Center Europe (NISSO CTAC EU)
Applicable field (uses covered by this announcement)
PharmaceuticalsHealth FoodsIndustrial applications
Launch dateNISSO CTAC EU opened in February 2026 (actual). Direct sales in India commenced in April 2026 (actual). The expanded production facilities at the 二本木工場 commenced operations in July 2026 (actual).
What the company reported numerically
Quantitative Effects

Production capacity increased to 1.5 times the previous level.

Relationship between the counterparty and the company
Nippon Soda Co.,Ltd.4041
Relationship with the Company

NISSO CHEMICAL EUROPE GmbH operates the company’s European technical center. The company conducts direct sales in India through NCI. It obtained EPD certification from SuMPO.

CounterpartyNisso Chemical India LLP(NCI)NISSO CHEMICAL EUROPE GmbHSustainable Management Promotion Organization (SuMPO)

NISSO CHEMICAL EUROPE GmbH operates NISSO CTAC EU. Nisso Chemical India LLP (NCI) is responsible for the company’s direct sales in India. SuMPO is an organization that certifies Environmental Product Declarations (EPDs). Other information on the locations, representatives, capital, and year of establishment is Not disclosed.

Award/certification name

Environmental Product Declaration (SuMPO EPD) certification

Awarding / certifying body

Sustainable Management Promotion Organization (SuMPO)

Registration number and expiry date

The number 2731 is shown on the URL of the official EPD page. The registration date and validity period are Not disclosed.

Location (as indicated in this announcement)

二本木工場 (Joetsu, Niigata Prefecture), Within the Life Science Center Düsseldorf (Germany), A local warehouse operated by a Japanese logistics company (India; detailed location is Not disclosed)

Production capacity is 1.5 times the previous level. The investment amount is ¥10 billion. Other information on the scale of the facilities is Not disclosed.
Impact on Business Performance

The initiative is described as part of efforts based on the long-term management vision and medium-term management plan, contributing to the enhancement of corporate value. Specific impacts on sales and profits are Not disclosed.

The company does not address Contract Value / Offering price.

Source (materials cited by the company)

Official SuMPO EPD page (https://ecoleaf-label.jp/epd/2731)

Announced details
ItemDetails
Names of Products / Services CoveredNISSO HPC, CELNY, Cellulose Technical Application Center Europe (NISSO CTAC EU)
CounterpartyNisso Chemical India LLP(NCI), NISSO CHEMICAL EUROPE GmbH, Sustainable Management Promotion Organization (SuMPO)
Counterparty overviewNISSO CHEMICAL EUROPE GmbH operates NISSO CTAC EU. Nisso Chemical India LLP (NCI) is responsible for the company’s direct sales in India. SuMPO is an organization that certifies Environmental Product Declarations (EPDs). Other information on the locations, representatives, capital, and year of establishment is Not disclosed.
Relationship with the CompanyNISSO CHEMICAL EUROPE GmbH operates the company’s European technical center. The company conducts direct sales in India through NCI. It obtained EPD certification from SuMPO.
Launch dateNISSO CTAC EU opened in February 2026 (actual). Direct sales in India commenced in April 2026 (actual). The expanded production facilities at the 二本木工場 commenced operations in July 2026 (actual).
Applicable areaPharmaceuticals, Health Foods, Industrial applications
Award/certification nameEnvironmental Product Declaration (SuMPO EPD) certification
Awarding / certifying bodySustainable Management Promotion Organization (SuMPO)
Registration number and expiry dateThe number 2731 is shown on the URL of the official EPD page. The registration date and validity period are Not disclosed.
Location二本木工場 (Joetsu, Niigata Prefecture), Within the Life Science Center Düsseldorf (Germany), A local warehouse operated by a Japanese logistics company (India; detailed location is Not disclosed)
Location scaleProduction capacity is 1.5 times the previous level. The investment amount is ¥10 billion. Other information on the scale of the facilities is Not disclosed.
Quantitative EffectsProduction capacity increased to 1.5 times the previous level.
Impact on Business PerformanceThe initiative is described as part of efforts based on the long-term management vision and medium-term management plan, contributing to the enhancement of corporate value. Specific impacts on sales and profits are Not disclosed.
SourceOfficial SuMPO EPD page (https://ecoleaf-label.jp/epd/2731)
Items this document does not state (4)
Contract ValueOffering priceContract DateUsage history

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To address growing global demand for pharmaceutical excipients and maximize the expanded production capacity.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Expansion of manufacturing facilities for the pharmaceutical excipient “NISSO HPC” completed; commercial operations commenced | Nippon Soda Co.,Ltd. (4041) timely disclosure | Komori